CD200R1 agonist attenuates glial activation, inflammatory reactions, and hypersensitivity immediately after its intrathecal application in a rat neuropathic pain model
Crossref DOI link: https://doi.org/10.1186/s12974-016-0508-8
Published Online: 2016-02-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hernangómez, Miriam
Klusáková, Ilona
Joukal, Marek
Hradilová-Svíženská, Ivana
Guaza, Carmen
Dubový, Petr
Funding for this research was provided by:
CEITEC (CZ.1.05/1.1.00/02.0068)
Employment of Newly Graduated Doctors of Science for Scientific Excellence (CZ.1.07/2.3.00/30.0009)